Esperance Pharmaceuticals, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 2006-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)โข Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
- First Posted Date
- 2011-12-06
- Last Posted Date
- 2014-06-10
- Lead Sponsor
- Esperance Pharmaceuticals Inc
- Target Recruit Count
- 49
- Registration Number
- NCT01485848
- Locations
- ๐บ๐ธ
Investigational Site Number 840001, Greenbrae, California, United States
๐บ๐ธInvestigational Site Number 840005, San Francisco, California, United States
๐บ๐ธInvestigational Site Number 840007, Louisville, Kentucky, United States
Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Solid TumorsAdvanced Solid Tumors
- First Posted Date
- 2009-07-30
- Last Posted Date
- 2012-04-04
- Lead Sponsor
- Esperance Pharmaceuticals Inc
- Target Recruit Count
- 38
- Registration Number
- NCT00949559
- Locations
- ๐บ๐ธ
TGEN Clinical Research Services at Scottsdale Healthcare, Scottsdale, Arizona, United States
๐บ๐ธMayo Clinic, Scottsdale, Arizona, United States
News
No news found